Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · IEX Real-Time Price · USD
0.841
+0.031 (3.79%)
At close: May 1, 2024, 3:59 PM
0.850
+0.009 (1.11%)
After-hours: May 1, 2024, 4:00 PM EDT
Cytosorbents Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Cytosorbents stock have an average target of 2.50, with a low estimate of 1.00 and a high estimate of 4.00. The average target predicts an increase of 197.37% from the current stock price of 0.84.
Analyst Consensus: Buy
* Price targets were last updated on Mar 15, 2024.
Analyst Ratings
The average analyst rating for Cytosorbents stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +18.95% | Mar 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $5.5 → $1 | Strong Buy → Hold | Downgrades | $5.5 → $1 | +18.95% | Dec 29, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +375.79% | Sep 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.5 | Strong Buy | Reiterates | $5.5 | +554.22% | Aug 2, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.5 | Strong Buy | Reiterates | $5.5 | +554.22% | May 3, 2023 |
Financial Forecast
Revenue This Year
41.11M
from 36.35M
Increased by 13.10%
Revenue Next Year
48.71M
from 41.11M
Increased by 18.49%
EPS This Year
-0.37
from -0.64
EPS Next Year
-0.21
from -0.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 43.4M | 52.2M | 55.0M | 95.0M |
| Avg | 41.1M | 48.7M | 53.4M | 92.3M |
| Low | 38.7M | 43.2M | 51.3M | 88.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 19.4% | 27.1% | 12.8% | 77.9% |
| Avg | 13.1% | 18.5% | 9.6% | 72.8% |
| Low | 6.5% | 5.1% | 5.3% | 66.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.33 | -0.17 | -0.16 | 0.16 |
| Avg | -0.37 | -0.21 | -0.15 | 0.15 |
| Low | -0.42 | -0.25 | -0.15 | 0.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.